 Cancer is one of the leading causes of death worldwide, with many current treatments being limited by their lack of specificity. Intervenous nanodrugs can build up in tumors due to the enhanced permeability and retention, EPR, effect, allowing them to reach much higher concentrations in tumors compared to other parts of the body. This review discusses the potential of using this phenomenon to target cancer cells specifically, as well as its limitations and prospects.